Search Count: 28
 |
Crystal Structure Of Sars-Cov-2 Mpro S10A In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-10
Ligands: V2M
 |
Crystal Structure Of Sars-Cov-2 Mpro S10C In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.99 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: DMS, EDO, V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-10
Ligands: DMS, EDO, V2M
 |
Crystal Structure Of Sars-Cov-2 Mpro S113A In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.97 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-10
Ligands: V2M
 |
Crystal Structure Of Sars-Cov-2 Mpro S113C In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.28 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-10
Ligands: V2M
 |
Crystal Structure Of Sars-Cov-2 Mpro L115A In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.21 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-10
Ligands: V2M
 |
Crystal Structure Of Sars-Cov-2 Mpro L115M In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.19 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-10
Ligands: V2M
 |
Crystal Structure Of Sars-Cov-2 Mpro S147A In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.13 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-10
Ligands: V2M
 |
Crystal Structure Of Sars-Cov-2 Mpro S147N In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.77 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-10
Ligands: V2M
 |
Co-Crystal Structure Of Feline Coronavirus Uu23 Main Protease With Pfizer Intravenous Compound Pf-00835231
Organism: Feline alphacoronavirus 1
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2025-11-26 Classification: VIRAL PROTEIN Ligands: V2M, ACY, PG4, EDO, PEG |
Organism: Feline alphacoronavirus 1
Method: X-RAY DIFFRACTION
Release Date: 2025-11-26
Ligands: V2M, ACY, PG4, EDO, PEG
 |
Crystal Structure Of Sars Main Protease In Complex With Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.61 Å Release Date: 2025-03-19 Classification: VIRAL PROTEIN Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-03-19
Ligands: V2M
 |
Crystal Structure Of Sars-Cov-2 Mpro Mutant E166A With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2025-03-19 Classification: VIRAL PROTEIN, HYDROLASE/HYDROLASE INHIBITOR Ligands: GOL, V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-03-19
Ligands: GOL, V2M
 |
Crystal Structure Of Sars-Cov-2 Mpro Mutant E166V With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2025-03-19 Classification: VIRAL PROTEIN, HYDROLASE/HYDROLASE INHIBITOR Ligands: GOL, V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-03-19
Ligands: GOL, V2M
 |
Crystal Structure Of Sars-Cov-2 Mpro Mutant L50F E166V With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.84 Å Release Date: 2025-03-19 Classification: VIRAL PROTEIN, HYDROLASE/HYDROLASE INHIBITOR Ligands: DMS, V2M, CL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-03-19
Ligands: DMS, V2M, CL
 |
Crystal Structure Of Sars-Cov-2 Main Protease M49I Mutant In Complex With Pf00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.21 Å Release Date: 2024-05-01 Classification: VIRAL PROTEIN/INHIBITOR Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-05-01
Ligands: V2M
 |
Crystal Structure Of Sars-Cov-2 Main Protease In Complex With Pf00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.21 Å Release Date: 2024-04-17 Classification: VIRAL PROTEIN/INHIBITOR Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-04-17
Ligands: V2M
 |
Crystal Structure Of Mers Main Protease In Complex With Pf00835231
Organism: Middle east respiratory syndrome-related coronavirus
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2024-04-17 Classification: VIRAL PROTEIN/INHIBITOR Ligands: V2M |
Organism: Middle east respiratory syndrome-related coronavirus
Method: X-RAY DIFFRACTION
Release Date: 2024-04-17
Ligands: V2M
 |
Crystal Structure Of Sars-Cov-2 Main Protease G15S Mutant In Complex With Pf00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2024-04-17 Classification: VIRAL PROTEIN/INHIBITOR Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-04-17
Ligands: V2M
 |
Crystal Structure Of Sars-Cov-2 Main Protease K90R Mutant In Complex With Pf00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.68 Å Release Date: 2024-04-17 Classification: VIRAL PROTEIN/INHIBITOR Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-04-17
Ligands: V2M
 |
Crystal Structure Of Sars-Cov-2 Main Protease P132H Mutant In Complex With Pf00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.72 Å Release Date: 2024-04-17 Classification: VIRAL PROTEIN/INHIBITOR Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-04-17
Ligands: V2M
 |
Crystal Structure Of Sars-Cov-2 Main Protease V186F Mutant In Complex With Pf00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.66 Å Release Date: 2024-04-17 Classification: VIRAL PROTEIN/INHIBITOR Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-04-17
Ligands: V2M